Morepen Laboratories500288Pharmaceuticals
Analysts gave a short-term target and hold recommendation for Morepen Laboratories ahead of its results
By ScoutQuest · · 1 min read
- Stock move today
- 2 to 3 percent
- One year rally
- 145 to 150 percent
- Stop loss
- 105
- Near term hurdle
- 125
- Upside target
- 135
Heard on business television between 14:07:43 - 14:10:43 IST.
- Shaina Mukaddam recommended holding until Q2 results next week, citing strong Q1 and bullish management commentary on CDMO order book.
- Stock up 2-3% in trade on the day; up 145-150% over the past year per Vaishali Parekh.
- Vaishali Parekh suggested a short-term stop loss of 105, with a near-term hurdle at 125 and target of 135 if crossed.
- Valuations seen attractive if growth guidance is met.
Watch at source
behind live
- 1Open on YouTube
- 2Drag the seek bar left
- 3Watch this moment
Also from Morepen Laboratories
Board meeting on 27 October 2026 to consider Q2 and H1 FY27 results
22 Oct 2026
High Court quashes GST show cause notice seeking ₹117.94 crore recovery
14 Oct 2026
First U.S. ANDA submitted to USFDA for Sitagliptin Tablets in three strengths
28 Sep 2026
Source: Live TV News Channel · 23 Oct 2026
The call above is Shaina Mukaddam's, reported here as they made it. Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.